Crossmark

Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System

Crossref DOI link: https://doi.org/10.1007/s13300-018-0545-7

Published Online: 2019-01-04

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, Yong

Ni, Wen-ji

Ding, BO

Xu, Xiang-hong

Ye, Lei

Ma, Jian-hua

Zhu, Jian https://orcid.org/0000-0002-4629-9883
Clinical Trials ^BETA

Clinical trials referenced in this document:

chictr1800015828 at Chinese Clinical Trial Registry

Documents that mention this clinical trial

Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System
https://doi.org/10.1007/s13300-018-0545-7
Funding

Funding for this research was provided by:

Scientific and Technological Development Program of Jiangsu Province (BL2014010)

The Nanjing Medical Science Fund for Distinguished Young Scholars (JQX12006)
License Information

Text and Data Mining valid from 2019-01-04

Version of Record valid from 2019-01-04
More Information

Article History

Received: 31 October 2018

First Online: 4 January 2019

Document is current

Any future updates will be listed below